Particles in Parenterals Summit
14-15

March 2019

Austria

Vienna

About

Vonlanthen Group is pleased to invite you to the Particles in Parenterals Summit scheduled for March 14th – 15th, 2019 in Vienna, Austria. At this summit, participants will be given the opportunity to discourse and network with peers involved in pharmaceutical manufacturing, quality control, automated inspection, and process engineering. Key topics regarding particles in parenterals will be discussed by some of the industry’s leading lights. This summit will give you an insight into current regulations for both the USA and the EU, inspection...

Vonlanthen Group is pleased to invite you to the Particles in Parenterals Summit scheduled for March 14th – 15th, 2019 in Vienna, Austria. At this summit, participants will be given the opportunity to discourse and network with peers involved in pharmaceutical manufacturing, quality control, automated inspection, and process engineering. Key topics regarding particles in parenterals will be discussed by some of the industry’s leading lights. This summit will give you an insight into current regulations for both the USA and the EU, inspection processes, and innovations in the manufacturing and administration of parenterals. We are delighted to give you the opportunity to participate in this Summit. We look forward to welcoming you in Vienna in March!

more info
Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Scientists, Engineers, Chemists, Biologists, and Fellows specialising in:

  • Analytical development
  • Formulation development
  • Manufacturing science and technology
  • Toxicology
  • Container development
  • Process Monitoring and Control
  • Safety assessments
  • Testing
  • Sterilisation
  • Filtration
  • Visual/automated inspection technology
  • QA/QC
  • Process and production engineering
  • Regulatory affairs
  • Device development
  • Parenterals
  • Risk management
  • Primary packaging
  • Materials science
  • Standardisation and validation
  • Aseptic environments
Key Practical Learning Points of the Summit

Annex 1 and other regulations governing Particles in Parenterals
Manual and semi-automated inspection of visible particles
Sub-visible particles: procedures and technology for detection and examination
Automated inspection pros and cons
Choosing, implementing, and validating inspection processes
How to minimize the presence of particles, from formulation to administration
Emerging technologies for the manufacturing and inspection of parenteral solutions
Root cause analysis: technology and methodology